APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzyme-Linked Immunosorbent Assay (ELISA) Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Analysis and Forecast 2026-2032

3 May 2026222 pages

Choose your research edition.

Industry ResearchEnzyme-Linked Immunosorbent Assay (ELISA) Service Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Analysis and Forecast 2026-2032222 pages · $4,950 USD

Market perspective

The global Enzyme-Linked Immunosorbent Assay (ELISA) Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Enzyme-Linked Immunosorbent Assay (ELISA) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Enzyme-Linked Immunosorbent Assay (ELISA) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Enzyme-Linked Immunosorbent Assay (ELISA) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Enzyme-Linked Immunosorbent Assay (ELISA) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Enzyme-Linked Immunosorbent Assay (ELISA) Service include Virology Research Services Ltd, ACROBiosystems, Boster Bio, RayBiotech, Inc, Precision Medicine Group, LLC, Bio-Techne, Cellular Technology Limited（immunospot）, Sino Biological, Inc and R&D Systems, Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Enzyme-Linked Immunosorbent Assay (ELISA) Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Enzyme-Linked Immunosorbent Assay (ELISA) Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Enzyme-Linked Immunosorbent Assay (ELISA) Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enzyme-Linked Immunosorbent Assay (ELISA) Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Enzyme-Linked Immunosorbent Assay (ELISA) Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Enzyme-Linked Immunosorbent Assay (ELISA) Service revenue, projected growth trends, production technology, application and end-user industry.

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Company

Virology Research Services Ltd

ACROBiosystems

Boster Bio

RayBiotech, Inc

Precision Medicine Group, LLC

Bio-Techne

Cellular Technology Limited（immunospot）

Sino Biological, Inc

R&D Systems, Inc

ProteoGenix

Eve Technologies

NorthEast BioAnalytical Laboratories LLC

mabtech

Pestka Biomedical Laboratories, Inc

Thermo Fisher Scientific

Antibodies Incorporated

Kaneka Eurogentec S.A

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Type

Routine ELISA Assays

Targeted Assay Development

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Application

Disease Diagnosis

Vaccine Effectiveness Evaluation

Drug Development

Allergen Testing

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme-Linked Immunosorbent Assay (ELISA) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzyme-Linked Immunosorbent Assay (ELISA) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme-Linked Immunosorbent Assay (ELISA) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Enzyme-Linked Immunosorbent Assay (ELISA) Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enzyme-Linked Immunosorbent Assay (ELISA) Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Routine ELISA Assays Major Player Table 3. Targeted Assay Development Major Player Table 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Disease Diagnosis Major Player Table 6. Vaccine Effectiveness Evaluation Major Player Table 7. Drug Development Major Player Table 8. Allergen Testing Major Player Table 9. Others Major Player Table 10. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Trends Table 11. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Drivers Table 12. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Opportunities and Challenges Table 13. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Restraints Table 14. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Region (2021-2026) Table 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Region (2027-2032) Table 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Players (2021-2026) Table 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Key Players Headquarters & Area Served Table 23. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Players, Product Type & Application Table 24. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Type (2021-2026) Table 31. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Type (2027-2032) Table 32. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Application (2021-2026) Table 36. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Application (2027-2032) Table 37. Virology Research Services Ltd Company Information Table 38. Virology Research Services Ltd Business Overview Table 39. Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 41. Virology Research Services Ltd Recent Development Table 42. ACROBiosystems Company Information Table 43. ACROBiosystems Business Overview Table 44. ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 46. ACROBiosystems Recent Development Table 47. Boster Bio Company Information Table 48. Boster Bio Business Overview Table 49. Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 51. Boster Bio Recent Development Table 52. RayBiotech, Inc Company Information Table 53. RayBiotech, Inc Business Overview Table 54. RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 56. RayBiotech, Inc Recent Development Table 57. Precision Medicine Group, LLC Company Information Table 58. Precision Medicine Group, LLC Business Overview Table 59. Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 61. Precision Medicine Group, LLC Recent Development Table 62. Bio-Techne Company Information Table 63. Bio-Techne Business Overview Table 64. Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 66. Bio-Techne Recent Development Table 67. Cellular Technology Limited（immunospot） Company Information Table 68. Cellular Technology Limited（immunospot） Business Overview Table 69. Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 71. Cellular Technology Limited（immunospot） Recent Development Table 72. Sino Biological, Inc Company Information Table 73. Sino Biological, Inc Business Overview Table 74. Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 76. Sino Biological, Inc Recent Development Table 77. R&D Systems, Inc Company Information Table 78. R&D Systems, Inc Business Overview Table 79. R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 81. R&D Systems, Inc Recent Development Table 82. ProteoGenix Company Information Table 83. ProteoGenix Business Overview Table 84. ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 86. ProteoGenix Recent Development Table 87. Eve Technologies Company Information Table 88. Eve Technologies Business Overview Table 89. Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 91. Eve Technologies Recent Development Table 92. NorthEast BioAnalytical Laboratories LLC Company Information Table 93. NorthEast BioAnalytical Laboratories LLC Business Overview Table 94. NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 96. NorthEast BioAnalytical Laboratories LLC Recent Development Table 97. mabtech Company Information Table 98. mabtech Business Overview Table 99. mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 101. mabtech Recent Development Table 102. Pestka Biomedical Laboratories, Inc Company Information Table 103. Pestka Biomedical Laboratories, Inc Business Overview Table 104. Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 106. Pestka Biomedical Laboratories, Inc Recent Development Table 107. Thermo Fisher Scientific Company Information Table 108. Thermo Fisher Scientific Business Overview Table 109. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 111. Thermo Fisher Scientific Recent Development Table 112. Antibodies Incorporated Company Information Table 113. Antibodies Incorporated Business Overview Table 114. Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 116. Antibodies Incorporated Recent Development Table 117. Kaneka Eurogentec S.A Company Information Table 118. Kaneka Eurogentec S.A Business Overview Table 119. Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 121. Kaneka Eurogentec S.A Recent Development Table 122. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021-2026) & (US$ Million) Table 128. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (US$ Million) & (2027-2032) Table 129. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021-2026) & (US$ Million) Table 135. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (US$ Million) & (2027-2032) Table 136. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026) & (US$ Million) Table 137. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032) & (US$ Million) Table 138. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026) & (US$ Million) Table 139. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026) & (US$ Million) Table 141. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032) & (US$ Million) Table 142. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Region (US$ Million) & (2021-2026) Table 146. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Region (US$ Million) & (2027-2032) Table 147. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026) & (US$ Million) Table 148. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032) & (US$ Million) Table 149. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026) & (US$ Million) Table 150. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032) & (US$ Million) Table 151. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021-2026) & (US$ Million) Table 153. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (US$ Million) & (2027-2032) Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Enzyme-Linked Immunosorbent Assay (ELISA) Service Image Figure 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Routine ELISA Assays Image Figure 5. Targeted Assay Development Image Figure 6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Disease Diagnosis Image Figure 9. Vaccine Effectiveness Evaluation Image Figure 10. Drug Development Image Figure 11. Allergen Testing Image Figure 12. Others Image Figure 13. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Type (2021-2032) Figure 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Application (2021-2032) Figure 24. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032) Figure 26. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032) Figure 27. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Country (2021-2032) Figure 28. United States Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032) Figure 33. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032) Figure 34. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Country (2021-2032) Figure 35. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032) Figure 45. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032) Figure 46. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032) Figure 48. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032) Figure 49. Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Region (2021-2032) Figure 50. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Country (2021-2032) Figure 60. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Routine ELISA Assays
  • Targeted Assay Development
Applications
  • Disease Diagnosis
  • Vaccine Effectiveness Evaluation
  • Drug Development
  • Allergen Testing
  • Others
Companies covered
  • Virology Research Services Ltd
  • ACROBiosystems
  • Boster Bio
  • RayBiotech, Inc
  • Precision Medicine Group, LLC
  • Bio-Techne
  • Cellular Technology Limited（immunospot）
  • Sino Biological, Inc
  • R&D Systems, Inc
  • ProteoGenix
  • Eve Technologies
  • NorthEast BioAnalytical Laboratories LLC
  • mabtech
  • Pestka Biomedical Laboratories, Inc
  • Thermo Fisher Scientific
  • Antibodies Incorporated
  • Kaneka Eurogentec S.A

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market by Type
  3. 1.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Routine ELISA Assays
  5. 1.2.3 Targeted Assay Development
  6. 1.3 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market by Application
  7. 1.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Disease Diagnosis
  9. 1.3.3 Vaccine Effectiveness Evaluation
  10. 1.3.4 Drug Development
  11. 1.3.5 Allergen Testing
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Dynamics
  1. 2.1 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Trends
  2. 2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Drivers
  3. 2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Opportunities and Challenges
  4. 2.4 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Perspective (2021-2032)
  2. 3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Growth Trends by Region
  3. 3.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Players
  2. 4.1.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Key Players Headquarters & Area Served
  7. 4.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Players, Product Type & Application
  8. 4.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market CR5 and HHI
  11. 4.6.3 2025 Enzyme-Linked Immunosorbent Assay (ELISA) Service Tier 1, Tier 2, and Tier 3
5 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Type
  1. 5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2032)
  3. 5.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Type (2021-2032)
6 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application
  1. 6.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2032)
  3. 6.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Virology Research Services Ltd
  2. 7.1.1 Virology Research Services Ltd Company Information
  3. 7.1.2 Virology Research Services Ltd Business Overview
  4. 7.1.3 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  6. 7.1.5 Virology Research Services Ltd Recent Developments
  7. 7.2 ACROBiosystems
  8. 7.2.1 ACROBiosystems Company Information
  9. 7.2.2 ACROBiosystems Business Overview
  10. 7.2.3 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  12. 7.2.5 ACROBiosystems Recent Developments
  13. 7.3 Boster Bio
  14. 7.3.1 Boster Bio Company Information
  15. 7.3.2 Boster Bio Business Overview
  16. 7.3.3 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  18. 7.3.5 Boster Bio Recent Developments
  19. 7.4 RayBiotech, Inc
  20. 7.4.1 RayBiotech, Inc Company Information
  21. 7.4.2 RayBiotech, Inc Business Overview
  22. 7.4.3 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  24. 7.4.5 RayBiotech, Inc Recent Developments
  25. 7.5 Precision Medicine Group, LLC
  26. 7.5.1 Precision Medicine Group, LLC Company Information
  27. 7.5.2 Precision Medicine Group, LLC Business Overview
  28. 7.5.3 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  30. 7.5.5 Precision Medicine Group, LLC Recent Developments
  31. 7.6 Bio-Techne
  32. 7.6.1 Bio-Techne Company Information
  33. 7.6.2 Bio-Techne Business Overview
  34. 7.6.3 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  36. 7.6.5 Bio-Techne Recent Developments
  37. 7.7 Cellular Technology Limited（immunospot）
  38. 7.7.1 Cellular Technology Limited（immunospot） Company Information
  39. 7.7.2 Cellular Technology Limited（immunospot） Business Overview
  40. 7.7.3 Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cellular Technology Limited（immunospot） Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  42. 7.7.5 Cellular Technology Limited（immunospot） Recent Developments
  43. 7.8 Sino Biological, Inc
  44. 7.8.1 Sino Biological, Inc Company Information
  45. 7.8.2 Sino Biological, Inc Business Overview
  46. 7.8.3 Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  48. 7.8.5 Sino Biological, Inc Recent Developments
  49. 7.9 R&D Systems, Inc
  50. 7.9.1 R&D Systems, Inc Company Information
  51. 7.9.2 R&D Systems, Inc Business Overview
  52. 7.9.3 R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  54. 7.9.5 R&D Systems, Inc Recent Developments
  55. 7.10 ProteoGenix
  56. 7.10.1 ProteoGenix Company Information
  57. 7.10.2 ProteoGenix Business Overview
  58. 7.10.3 ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  60. 7.10.5 ProteoGenix Recent Developments
  61. 7.11 Eve Technologies
  62. 7.11.1 Eve Technologies Company Information
  63. 7.11.2 Eve Technologies Business Overview
  64. 7.11.3 Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  66. 7.11.5 Eve Technologies Recent Developments
  67. 7.12 NorthEast BioAnalytical Laboratories LLC
  68. 7.12.1 NorthEast BioAnalytical Laboratories LLC Company Information
  69. 7.12.2 NorthEast BioAnalytical Laboratories LLC Business Overview
  70. 7.12.3 NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  72. 7.12.5 NorthEast BioAnalytical Laboratories LLC Recent Developments
  73. 7.13 mabtech
  74. 7.13.1 mabtech Company Information
  75. 7.13.2 mabtech Business Overview
  76. 7.13.3 mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  78. 7.13.5 mabtech Recent Developments
  79. 7.14 Pestka Biomedical Laboratories, Inc
  80. 7.14.1 Pestka Biomedical Laboratories, Inc Company Information
  81. 7.14.2 Pestka Biomedical Laboratories, Inc Business Overview
  82. 7.14.3 Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  84. 7.14.5 Pestka Biomedical Laboratories, Inc Recent Developments
  85. 7.15 Thermo Fisher Scientific
  86. 7.15.1 Thermo Fisher Scientific Company Information
  87. 7.15.2 Thermo Fisher Scientific Business Overview
  88. 7.15.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  90. 7.15.5 Thermo Fisher Scientific Recent Developments
  91. 7.16 Antibodies Incorporated
  92. 7.16.1 Antibodies Incorporated Company Information
  93. 7.16.2 Antibodies Incorporated Business Overview
  94. 7.16.3 Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  96. 7.16.5 Antibodies Incorporated Recent Developments
  97. 7.17 Kaneka Eurogentec S.A
  98. 7.17.1 Kaneka Eurogentec S.A Company Information
  99. 7.17.2 Kaneka Eurogentec S.A Business Overview
  100. 7.17.3 Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  102. 7.17.5 Kaneka Eurogentec S.A Recent Developments
8 North America
  1. 8.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2021-2032)
  2. 8.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032)
  5. 8.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032)
  9. 8.5 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country
  11. 8.6.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2021-2032)
  2. 9.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032)
  5. 9.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032)
  9. 9.5 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country
  11. 9.6.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2021-2032)
  2. 10.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2032)
  3. 10.2.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026)
  4. 10.2.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032)
  5. 10.3 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032)
  6. 10.4 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2032)
  7. 10.4.1 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026)
  8. 10.4.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032)
  9. 10.5 China Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2021-2032)
  2. 11.2 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032)
  5. 11.3 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032)
  9. 11.5 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country
  11. 11.6.1 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue (2021-2032)
  2. 12.2 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country
  11. 12.6.1 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst